Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
6
Bullish
4
Bearish
26
Neutral
6
Bullish
14
Bearish
22
Neutral
0
Bullish
10
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q2 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q2 FY24
Unihealth Hospitals Ltd (UNIHEALTH) is currently trading at 543.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Unihealth Hospitals Limited operates an integrated healthcare platform providing multi‑specialty hospital operations, healthcare consultancy, medical value travel, pharmaceutical distribution and project management, with an asset‑light expansion model focused on India and East Africa across owned and managed facilities. FY26 was a transformational year: consolidated total income rose 34.6% to INR137 crores, EBITDA increased nearly 49% to INR58.8 crores and EBITDA margin expanded over 400 basis points to 42.9%, while PAT grew approximately 83% to INR25.8 crores, reflecting strong utilization improvements and operating leverage across mature assets. The group materially scaled capacity during FY26—commissioning Navi Mumbai, completing the Nashik lease and acquiring/commissioning UMC Entebbe—doubling bed capacity from ~200 to ~400 beds and creating a cross‑border platform that the company expects to monetize through higher occupancy, specialty services and medical tourism flows. Near‑term operational targets include achieving operational breakeven at Navi Mumbai by end of Q2 FY27, commissioning Nashik in early July, expecting Tanzania secondary facility license and targeting about 600 commissioned beds by FY27. Management targets a longer‑term 1,000 commissioned beds by calendar 2028 with consolidated EBITDA margins in the early‑30s once network matures.
Over the past 52 weeks, Unihealth Hospitals Ltd has traded between a low of ₹153.55 and a high of ₹820.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Unihealth Hospitals Ltd has a market capitalization of approximately 864.72. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Unihealth Hospitals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.48 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 864.72 Cr, Unihealth Hospitals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Unihealth Hospitals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Unihealth Hospitals Ltd is 33.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Healthcare Services
Hospital
865 Cr
Low Risk
33.5
60.9
0.4
6.2
820.00
153.55
Sales CAGR
Profit CAGR
ROE
ROCE
